Literature DB >> 24028073

CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders.

A Dudesek1, F Rimmele, S Tesar, S Kolbaske, P S Rommer, R Benecke, U K Zettl.   

Abstract

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a recently defined inflammatory central nervous system (CNS) disorder, prominently involving the brainstem and in particular the pons. The condition features a combination of clinical symptoms essentially referable to brainstem pathology and a characteristic magnetic resonance imaging (MRI) appearance with punctate and curvilinear gadolinium enhancement 'peppering' the pons. The radiological distribution is focused in the pons and adjacent rhombencephalic structures such as the cerebellar peduncles, cerebellum, medulla and the midbrain. While the lesion burden with a perivascular pattern is typically most dense in these pontine and peripontine regions, enhancing lesions may additionally extend into the spinal cord and supratentorial structures such as the thalamus, basal ganglia, capsula interna, corpus callosum and the cerebral white matter. Another core feature is clinical and radiological responsiveness to glucocorticosteroid (GCS)-based immunosuppression. As withdrawal of GCS treatment results commonly in disease exacerbation, long-term immunosuppressive therapy appears to be mandatory for sustained improvement. Diagnosis of CLIPPERS is challenging, and requires careful exclusion of alternative diagnoses. A specific serum or cerebrospinal fluid (CSF) biomarker for the disorder is currently not known. Pathogenesis of CLIPPERS remains poorly understood, and the nosological position of CLIPPERS has still to be established. Whether CLIPPERS represents an independent, actual new disorder or a syndrome that includes aetiologically heterogeneous diseases and/or their prestages remains a debated and not finally clarified issue. Clinicians and radiologists should be aware of this condition and its differential diagnoses, given that CLIPPERS constitutes a treatable condition and that patients may benefit from an early introduction of GCS ensued by long-term immunosuppression. Based on previous reports in literature - currently encompassing more than 50 reported cases of CLIPPERS - this review addresses clinical features, diagnostic criteria, differential diagnoses and therapeutic management of this peculiar disorder.
© 2013 British Society for Immunology.

Entities:  

Keywords:  CLIPPERS; brainstem; glucocorticosteroids; neuroinflammation; perivascular infiltration

Mesh:

Substances:

Year:  2014        PMID: 24028073      PMCID: PMC3927899          DOI: 10.1111/cei.12204

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Brain biopsy in cryptogenic neurological disease.

Authors:  Claire M Rice; Catherine E Gilkes; Emily Teare; Richard J Hardie; Neil J Scolding; Richard J Edwards
Journal:  Br J Neurosurg       Date:  2011-04-18       Impact factor: 1.596

3.  A new case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids with initial normal magnetic resonance imaging.

Authors:  Guillaume Taieb; Anne Wacongne; Dimitri Renard; Dominique Figarella-Branger; Giovanni Castelnovo; Pierre Labauge
Journal:  Brain       Date:  2011-02-08       Impact factor: 13.501

4.  'Radiologically compatible CLIPPERS' may conceal a number of pathologies.

Authors:  Joanne L Jones; Andrew F Dean; Nagui Antoun; Daniel J Scoffings; Neil G Burnet; Alasdair J Coles
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

5.  Atypical chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS), primary angiitis of the CNS mimicking CLIPPERS or overlap syndrome? A case report.

Authors:  Mathias Buttmann; Imke Metz; Isabel Brecht; Wolfgang Brück; Monika Warmuth-Metz
Journal:  J Neurol Sci       Date:  2012-11-11       Impact factor: 3.181

6.  Brain biopsy is required in steroid-resistant patients with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  Nadège Limousin; Julien Praline; Oana Motica; Jean Philippe Cottier; Cecilia Rousselot-Denis; Karima Mokhtari; Alberto Gonzalez-Aguilar; Bertrand De Toffol
Journal:  J Neurooncol       Date:  2011-10-04       Impact factor: 4.130

7.  Response to immunotherapy in CLIPPERS: clinical, MRI, and MRS follow-up.

Authors:  Angel P Sempere; Santiago Mola; Patricia Martin-Medina; Angela Bernabeu; Elias Khabbaz; Susana Lopez-Celada
Journal:  J Neuroimaging       Date:  2011-08-17       Impact factor: 2.486

Review 8.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nat Rev Neurol       Date:  2010-07       Impact factor: 42.937

9.  3.0T MR investigation of CLIPPERS: role of susceptibility weighted and perfusion weighted imaging.

Authors:  Ilaria Pesaresi; Mario Sabato; Ilaria Desideri; Michele Puglioli; Policarpo Moretti; Mirco Cosottini
Journal:  Magn Reson Imaging       Date:  2013-08-19       Impact factor: 2.546

10.  Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.

Authors:  Hjalmar J De Graaff; Mike P Wattjes; Annemieke J Rozemuller-Kwakkel; Axel Petzold; Joep Killestein
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

View more
  24 in total

1.  Two New Cases and Literature Review of CLIPPERS Syndrome with Long-Term Follow-up.

Authors:  Özden Kamişli; Mehmet Tecellioğlu; Mehmet Fatih Erbay; Suat Kamişli; Cemal Özcan
Journal:  Noro Psikiyatr Ars       Date:  2017-11-08       Impact factor: 1.339

2.  Neuroinflammation of the central and peripheral nervous system: an update.

Authors:  O Stüve; U Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

3.  Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS.

Authors:  Mkael Symmonds; Patrick J Waters; Wilhelm Küker; M Isabel Leite; Ursula G Schulz
Journal:  Neurology       Date:  2015-02-13       Impact factor: 9.910

4.  Hemidysgeusia, phantosmia and respiratory arrest: a case of CLIPPERS.

Authors:  Peter Baoviet Nguyen; David Prentice; Robert Brazel; Wai Kuen Leong
Journal:  BMJ Case Rep       Date:  2019-05-30

Review 5.  Brain miliary enhancement.

Authors:  Joseph C J Bot; Linda Mazzai; Rogier E Hagenbeek; Silvia Ingala; Bob van Oosten; Esther Sanchez-Aliaga; Frederik Barkhof
Journal:  Neuroradiology       Date:  2020-01-10       Impact factor: 2.804

6.  Area postrema involvement in chronic lymphocytic inflammation with pontine perivascular enhancement.

Authors:  Aigli Vakrakou; Vasilios Constantinides; George P Paraskevas; Kostas Kilidireas; Leonidas Stefanis; Elisabeth Kapaki
Journal:  Neurol Sci       Date:  2020-07-22       Impact factor: 3.307

7.  Misdiagnosis: CNS Erdheim-Chester disease mimicking CLIPPERS.

Authors:  Jillian Berkman; Caleb Ford; Emily Johnson; Beth A Malow; Joseph M Aulino
Journal:  Neuroradiol J       Date:  2017-07-07

Review 8.  CLIPPERS.

Authors:  Nicholas L Zalewski; W Oliver Tobin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

9.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, a mimicker of malignancy: a case report and review of the literature.

Authors:  Eric Zhuang; Lisa Shane; Nima Ramezan; Ameera F Ismail; Nilesh L Vora
Journal:  J Med Case Rep       Date:  2021-05-18

10.  CLIPPERS associated with hypersensitivity pneumonitis: a case report.

Authors:  Maria Andrea Parra Corral; Jose Gavito-Higuera; Thomas O'Neill; Sajeev R Ezhapilli Chennan
Journal:  Radiol Case Rep       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.